Suzhou Basecare Medical (HKSE:02170) EV-to-Revenue : -0.80 (As of Jun. 21, 2024)

View and export this data going back to 2021. Start your Free Trial

What is Suzhou Basecare Medical EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Suzhou Basecare Medical's enterprise value is HK$-181.1 Mil. Suzhou Basecare Medical's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was HK$227.5 Mil. Therefore, Suzhou Basecare Medical's EV-to-Revenue for today is -0.80.

The historical rank and industry rank for Suzhou Basecare Medical's EV-to-Revenue or its related term are showing as below:

HKSE:02170' s EV-to-Revenue Range Over the Past 10 Years
Min: -8.34 Med: -0.93 Max: 90.1
Current: -0.8

During the past 6 years, the highest EV-to-Revenue of Suzhou Basecare Medical was 90.10. The lowest was -8.34. And the median was -0.93.

HKSE:02170's EV-to-Revenue is ranked better than
98.18% of 825 companies
in the Medical Devices & Instruments industry
Industry Median: 3.01 vs HKSE:02170: -0.80

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-06-21), Suzhou Basecare Medical's stock price is HK$1.96. Suzhou Basecare Medical's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was HK$0.83. Therefore, Suzhou Basecare Medical's PS Ratio for today is 2.36.

Suzhou Basecare Medical EV-to-Revenue Historical Data

The historical data trend for Suzhou Basecare Medical's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Suzhou Basecare Medical EV-to-Revenue Chart

Suzhou Basecare Medical Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EV-to-Revenue

Get a 7-Day Free Trial

0.20

-2.44

-0.36

Suzhou Basecare Medical Semi-Annual Data
	Dec18	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
EV-to-Revenue	Get a 7-Day Free Trial					0.20	-	-2.44	-	-0.36

Competitive Comparison of Suzhou Basecare Medical's EV-to-Revenue

For the Medical Devices subindustry, Suzhou Basecare Medical's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Suzhou Basecare Medical's EV-to-Revenue Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Suzhou Basecare Medical's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Suzhou Basecare Medical's EV-to-Revenue falls into.

Suzhou Basecare Medical EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Suzhou Basecare Medical's EV-to-Revenue for today is calculated as:

EV-to-Revenue	=	Enterprise Value (Today)	/	Revenue (TTM)
	=	-181.052	/	227.48
	=	-0.80

Suzhou Basecare Medical's current Enterprise Value is HK$-181.1 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Suzhou Basecare Medical's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was HK$227.5 Mil.

Suzhou Basecare Medical (HKSE:02170) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Suzhou Basecare Medical's PS Ratiofor today is calculated as:

PS Ratio	=	Share Price (Today)	/	Revenue per Share (TTM)
	=	1.96	/	0.832
	=	2.36

Suzhou Basecare Medical's share price for today is HK$1.96.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. {COMPANY->company}'s Revenue per Sharefor the trailing twelve months (TTM) ended in Dec. 2023 was HK$0.83.

Suzhou Basecare Medical EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Suzhou Basecare Medical's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Suzhou Basecare Medical (HKSE:02170) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Suzhou Basecare Medical Corp Ltd (HKSE:02170) » Definitions » EV-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

BioBay, No. 218 Xinghu Street, Unit 101, Building A3, Suzhou Industrial Park, Jiangsu Province, Suzhou, CHN, 215000

Website

https://www.basecare.cn

Suzhou Basecare Medical Corp Ltd is engaged in providing genetic testing solutions for assisted human reproduction. The company generates revenues from Sales of testing kits, followed by Sales of testing devices and instruments. Basecare focuses on the assisted reproductive sector, such as pre-implantation genetic screening and diagnosis, non-invasive prenatal DNA testing, and chromosome abnormalities testing. It generates revenue from China.

Executives

Orbimed Capital Llc	2102 Investment manager
Lake Bleu Prime Healthcare Master Fund Limited	2201 Interest of corporation controlled by you
Orbimed Partners Master Fund Limited	2101 Beneficial owner
Dawn Capital Fund	2101 Beneficial owner
Dawn Capital Limited	2102 Investment manager
Hh Spr-xiv Cy Holdings Limited	2201 Interest of corporation controlled by you
Hh Spr-xiv Hk Holdings Limited	2101 Beneficial owner
Hh Spr-xiv Holdings L.p.	2201 Interest of corporation controlled by you
Hillhouse Fund Iv, L.p.	2201 Interest of corporation controlled by you
Hillhouse Investment Management, Ltd.	2102 Investment manager

Suzhou Basecare Medical (HKSE:02170) Headlines

No Headlines